Anagram & Information om | Engelska ordet DMARDS

Exempel på hur man kan använda DMARDS i en mening

• Disease-modifying antirheumatic drugs (DMARDs) comprise a category of otherwise unrelated disease-modifying drugs defined by their use in rheumatoid arthritis to slow down disease progression.
• Cyclophosphamide decreases the immune system's response, and although concerns about toxicity restrict its use to patients with severe disease, it remains an important treatment for life-threatening autoimmune diseases where disease-modifying antirheumatic drugs (DMARDs) have been ineffective.
• Treatments for inflammatory arthritis vary by subtype, though they may include drugs like DMARDs (disease-modifying anti-rheumatic drugs) and tumor necrosis factor inhibitors.
• Tocilizumab is used for the treatment of moderate to severe rheumatoid arthritis, applied in combination with methotrexate, if other drugs like disease-modifying antirheumatic drugs (DMARDs) and TNF alpha blockers have proven to be ineffective or were not tolerated.
• Taken together, extracellular 14-3-3η upregulates pro-inflammatory factors directly that are targeted with small molecules and/or biological Disease-modifying antirheumatic drug (DMARDs), including TNF, IL-6 and Janus kinases.
• It can be used alone or in combination with methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
• In the European Union, apremilast alone or in combination with disease-modifying antirheumatic drugs (DMARDs), is indicated for the treatment of active psoriatic arthritis (PsA) in adults who have had an inadequate response or who have been intolerant to a prior DMARD therapy.
• Upadacitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs).
• Immunosuppressive drugs are categorized into DMARDs (disease-modifying anti-rheumatic drugs), as well as.
• Pharmacological interventions include NSAIDs (naproxen, ibuprofen, and indomethacin), intra-articular corticosteroid (IAC) injections like triamcinolone hexacetonide (TH), conventional DMARDs (Methotrexate), and TNF inhibitors such as Etanercept.
• His research findings and health technology assessment reports have contributed to the development of biological disease-modifying antirheumatic drugs (DMARDs) therapies (infliximab, etanercept, tocilizumab, rituximab, abatacept) have become publicly funded in Hungary and patients with rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis and psoriasis have access to appropriate therapy.

Förberedelsen av sidan tog: 363,10 ms.